Zynex Inc, a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has been ranked 191 out of 500 on The Financial Times fourth annual list of The Americas’ Fastest Growing Companies 2023.
This is the second consecutive year Zynex has appeared on this Financial Times list.
Related: Zynex Adds Knee Bracing to Its Pain Management Division
“Zynex has consistently grown revenue and profitability over the last several years and we are pleased that our performance has been recognized alongside other innovative organizations,” says Thomas Sandgaard, CEO and founder of Zynex. “The Company grew revenue by 308% and achieved a compound annual growth rate (CAGR) of 60% between 2018 and 2021, when the data for the rankings was collected. Additionally, we are pleased to be one of twenty-four publicly traded Healthcare & Life Sciences companies recognized in this high growth category.”
The full list is available at: The Americas’ Fastest Growing Companies 2023
The Denver Business Journal also recently ranked Zynex sixth in a list of the largest Denver-area Biotechnology/Bioscience companies, according to the number of full-time employees (FTEs).
“We remain committed to being a high-quality workplace and industry leader in the Denver-area,” Sandgaard remarked when Zynex, based in Englewood, Colorado, was named to the list.
